Rigel Pharmaceuticals Inc (RIGL): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$450.0K
Year ended 2022-12-31
-32.4%
3-year compound annual growth
+22.4%
5-year compound annual growth
-18.3%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $450.0K | -28.2% | 2024-03-05, From 2022-01-01 |
| 2021-12-31 | $627.0K | -50.3% | 2024-03-05, From 2021-01-01 |
| 2020-12-31 | $1.26M | -13.3% | 2023-03-07, From 2020-01-01 |
| 2019-12-31 | $1.46M | +31.6% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $1.11M | +574.4% | 2021-03-02, From 2018-01-01 |
| 2017-12-31 | $164.0K | -79.6% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $804.0K | +47.3% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $546.0K | +32.2% | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | $413.0K | -66.2% | 2017-03-07, From 2014-01-01 |
| 2013-12-31 | $1.22M | -63.8% | 2016-03-08, From 2013-01-01 |
| 2012-12-31 | $3.38M | +46.6% | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | $2.30M | -35.3% | 2014-03-04, From 2011-01-01 |
| 2010-12-31 | $3.56M | n/m | 2013-03-05, From 2010-01-01 |
| 2009-12-31 | $141.0K | n/a | 2012-03-06, From 2009-01-01 |